This page is the continuation of reference in support of Section 5a.
REFERENCES
Allred, D.C., Wu, Y., Mao, S., et al. (2008). Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res. 14(2), 370-378. (Retrieved November 6th 2014): http://clincancerres.aacrjournals.org/content/14/2/370.abstract?ijkey=bc8a60dd7a27f0d27049f08e9a718504d8736972&keytype2=tf_ipsecsha
Allred, D.C. Biological features of human premalignant breast disease and the progression to cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2009.
Allred, D.C. (2010). Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr. 41:134-8. (Retrieved November 6th 2014): https://academic.oup.com/jncimono/article/2010/41/134/890446
American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 7th edition, Edge, S.B., Byrd, D.R., Compton, C.C., et al (Eds), Springer, New York 2010.
Bernstein, L. The epidemiology of breast carcinoma in situ. In: Silverstein ML, editor. Ductal Carcinoma In Situ of the Breast. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2002.
Bijker, N., Meijnen, P., Peterse, J.L., et al. (2006). Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III Trial 10853—A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381-3387. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16801628
Bloom, H.J., Richardson, W.W. (1957). Histological grading and prognosis in breast cancer. A study of 1,409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3), 359-377. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2073885/
Bradley, S.J., Weaver, D.W., Bowman, D.L. (1990). Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome. Am J Surg 56(7):428. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/2164336
Cayari, R., McGuire, L., Weinstein, S., Lakhani, S. (2010). Mucoepidermoid carcinoma of the breast. A case report and review of the literature. 42,81. (Retrieved November 14th 2014): https://journals.lww.com/pathologyrcpa/Fulltext/2010/42001/1
Chuba, P.J., Hamre, M.R., Yap, J., Severson, R.K., Lucas, D., Shamsa, F., Aref, A. (2005). Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 23(24):5534. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16110014
Collins, L.C., Baer, H.J., Tamimi, R.M., Connolly, J.L., Colditz, G.A., Schnitt, S.J. (2007). Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer 109(2), 180. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/17154175
Elston, C.W., Ellis, I.O. (1991). Pathologic prognostic factors in breast cancer. I. The value of histological grades in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19(5), 403–10. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/1757079
Hughes, L.L., Wang, M., Page, D.L., Gray, R., Solin, L.J., Davidson, N.E., Lowen, M.A., Ingle, J.N., Recht, A., Wood, W.C. (2009). Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27(32), 5319. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773217/
Lakhani, S., Ellis, I., Schnitt, S., et al. (2012). WHO Classification of Tumours of the Breast, 4th ed. Lyon, IARC Press. (Retrieved November 6th 2014): http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4004
Li, C.I., Anderson, B.O., Daling, J.R., Moe, R.E. (2003). Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289, 1421–1424. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/12636465
Li, C.I., Uribe, D.J., Daling, J.R. (2005). Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9),1046. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361680/
National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. (Retrieved November 6th 2014): http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P. (1982).Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5, 649-655. (Retrieved November 14th 2014): http://www.ncbi.nlm.nih.gov/pubmed/7165009 http://www.npcrc.org/files/news/ECOG_performance_status.pdf
Orvieto, E., Maiorano, E., Bottiglieri, L., Maisonneuve, P., Rotmensz, N., Galimberti, V., Luini, A., Brenelli, F., Gatti, G., Viale, G. (2008). Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer. 2008;113(7):1511. (Retrieved November 14th 2014): th 2014): http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(03)12230-1/fulltext
Pradier, C., Cornuau, M., Norca, J., Mesbah, H., Poree, P., Body, G., Classe, J-M, Leveque, J. (2011). Differences in Breast Carcinoma In Situ Between Menopausal and Premenopausal Women. Anticancer Res 31 (5), 1783-1788. (Retrieved November 13th 2014): http://ar.iiarjournals.org/search?author1=PHILIPPE+POREE&sortspec=date&submit=Submit
Rakha, E.A., El-Sayed, M.E., Lee, A.H., Elston, C.W., Grainge, M.J., Hodi, Z., Blamey, R.W., Ellis, I.O. (2008). Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol. 26(19), 3153-8. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/18490649
Rakha, E.A., Ellis, I.O. (2010). Lobular breast carcinoma and its variants. Semin Diagn Pathol 27(1), 49-61. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/20306830
Rakha, E.A., van Deurzen, C.H., Paish, E.C., Macmillan, R.D., Ellis, I.O., Lee, A.H. (2013). Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade? Mod Pathol 26(4), 496-501. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/23238630
Rosen, P.P., Oberman, H. Tumors of the Mammary Gland, Armed Forces Institute of Pathology, Washington, DC 1993.
Schairer, C., Mink, P.J., Carroll, L., et al. (2004). Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96, 1311-1321. (Retrieved November 6th 2014): https://academic.oup.com/jnci/article/96/17/1311/2520929
Schonberg, M.A., Marcantonio, E.R., Ngo, L., Li, D., Silliman, R.A., McCarthy, E.P. (2011). Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol 29(12), 1570. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/21402602
Silverstein, M.J., Waisman, J.R., Gamagami, P. et al. (1990). Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice. Cancer 66, 102. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/2162238
Silverstein, M.J., Lagios, M.D., Craig, P.H., Waisman, J.R., Lewinsky, B.S., Colburn, W.J., Poller, D.N. (1996). A prognostic index for ductal carcinoma in situ of the breast. Cancer 77(11), 2267. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/8635094
Simpson, J.L., Page, D.L. (1996). The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancer. Semin Oncol. 23(4), 428-35. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/8757269
Sinn, H-P., Kreipe, H. (2013). A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition. Breast Care (Basel) 8(2), 149–154. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683948/
Solin, L.J., Fourquet, A., Vicini, F.A. et al. (2005). Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103(6), 1137. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/15674853
Tavassoli, F.A., Devilee, P. (eds): Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, IARC Press, 2003.
Thurman, S.A., Schnitt, S.J., Connolly, J.L., Gelman, R., Silver, B., Harris, J.R., Recht, A. (2004). Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys 59(1), 152. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/15093911
